Beryllium and lung cancer: A weight of evidence evaluation of the toxicological and epidemiological literature

Critical Reviews in Toxicology

Volumn 39, Issue SUPPL.1, 2009, Pages

  Hollins, D M ^a   McKinley, M A ^a   Williams, C ^a   Wiman, A ^a   Fillos, D ^a   Chapman, P S ^a   Madl, A K ^a  

^a CARDNO CHEMRISK   (United States)

Author keywords

Beryllium; Epidemiology; IARC; Lung cancer; Toxicology

Indexed keywords

BERYLLIUM;

CANCER INCIDENCE; CANCER RISK; CLINICAL EVALUATION; CLINICAL FEATURE; ENDOBRONCHIAL INTUBATION; HEALTH SERVICE; HISTORY OF MEDICINE; HUMAN; LUNG CANCER; LUNG CARCINOGENESIS; MEDICAL LITERATURE; NONHUMAN; REVIEW;

ANIMALS; BERYLLIUM; CARCINOGENICITY TESTS; CARCINOGENS, ENVIRONMENTAL; EPIDEMIOLOGIC STUDIES; HUMANS; LUNG NEOPLASMS; RISK ASSESSMENT;

ANIMALIA;

EID: 70350510066     PISSN: 10408444     EISSN: 15476898     Source Type: Journal    
DOI: 10.1080/10408440902837967     Document Type: Review

References (159)

1. ACGIH. 1996. Documentation of threshold limit values for beryllium and compounds. Cincinnati, OH: American Conference of Governmental Industrial Hygenists.
2. ACGIH. 2001. Documentation of threshold limit values for beryllium and compounds. Cincinnati, OH: American Conference of Governmental Industrial Hygenists.
3. ACGIH. 2008. Draft Documentation of threshold limit values for beryllium and compounds. Cincinnati, OH: American Conference of Governmental Industrial Hygenists.
4. Amand, W. B., W. H. Riser, and D. N. Biery. 1973. Spontaneous osteosarcoma with widespread meastasis in a belted dutch rabbit. J Am Anim Hosp Assoc 9:577-581.
5. Ames, B. N., and L. S. Gold. 1990. Chemical carcinogenesis: too many rodent carcinogens. Proc Natl Acad Sci USA 87(19):7772-7776.
6. Araki, M., S. Okada, and M. Fujita. 1954. Beryllium. Experimental studies on beryllium-induced malignant tumours of rabbits (Jpn.). Gann 45:449-451.
7. Ashby, J., M. Ishidate, Jr., G. D. Stoner, M. A. Morgan, F. Ratpan, and R. D. Callander. 1990. Studies on the genotoxicity of beryllium sulphate in vitro and in vivo. Mutat Res 240(3):217-225.
8. ATSDR. 2002. Toxicological profle for beryllium. Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry.
9. Axelson, O., and K. Steenland. 1988. Indirect mthods of assessing the efects of tobacco use in occupational studies. Am J Ind Med 13:105-118.
10. Barnes, J. M. 1950. Experimental production of malignant tumours by beryllium. Lancet 255:463.
11. Barnes, J. M., and F. A. Denz. 1950. Beryllium bone sarcomata in rabbits. Br J Cancer 4(2):212-222.
12. Bayliss, D. L. 1980. Letter to William H. Foege, M.D., Director, Center for Disease Control. Atlanta, GA.
13. Bayliss, D. L., W. S. Lainhart, L. J. Crally, R. Ligo, H. Ayer, and F. Hunter. 1971. Mortality patterns in a group of former beryllium workers. Paper read at thirty-third annual meeting of the American Conference of Governmental Industrial Hygienists, May 24-28, 1971, at Toronto, Canada.
14. BISAC (Beryllium Industry Scientifc Advisory Committee). 1997. Is beryllium carcinogenic in humans? J Occup Environ Med 39(3):205-208.
15. Blair, A., K. Steenland, C. Shy, M. O'Berg, W. Halperin, and T. Tomas. 1988. Control of smoking in occupational epidemiologic studies: methods and needs. Am J Ind Med 13(1):3-4.
16. Borak, J. 2006. Te beryllium occupational exposure limit: Historical origin and current inadequacy J Occup Environ Med 48:109-116.
17. Brown, C. C., and L. G. Kessler. 1988. Projections of lung cancer mortality in the United States: 1985-2025. J Natl Cancer Inst 80(1):43-51.
18. Brown, S. C., M. F. Schonbeck, D. McClure, A. E. Baron, W. C. Navidi, T. Byers, and A. J. Ruttenber. 2004. Lung cancer and internal lung doses among plutonium workers at the Rocky Flats Plant: A case-control study. Am J Epidemiol 160(2):163-172.
19. Browne, K. 1986. Is asbestos or asbestosis the cause of the increased risk of lung cancer in asbestos workers? Br J Ind Med 43:145-149.
20. Carpenter, A. V. , W. D. Flanders, E. L. Frome, W. G. Tankersley, and S. A. Fry. 1988. Chemical exposures and central nervous system cancers: A case-control study among workers at two nuclear facilities. Am J Ind Med 13(3):351-362.
21. Checkoway, H., N. Pearce, and D. Kriebel. 2004. Research Methods in Occupational Epidemiology. 2nd ed. Vol.34, Monographs in Epidemiology and Biostatistics. New York: Oxford University Press.
22. Checkoway, H., N. Pearce, J. L. Hickey, and J. M. Dement. 1990. Latency anal ysis in occupational epidemiology. Arch Environ Health 45(2): 95-100.
23. Chiba, I., T. Takahashi, M. M. Nau, D. D'Amico, D. T. Curiel, T. Mitsudomi, D. L. Buchhagen, D. Carbone, S. Piantadosi, H. Koga, et al. 1990. Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group. Oncogene 5(10):1603-1610.
24. Cloudman, A. M., D. Vining, S. Barkulis, and J. J. Nickson. 1949. Bone changes observed following intravenous injection of beryllium. Am J Pathol 25:810-811.
25. Davies, J. M. 1984. Lung cancer mortality among workers making lead chromate and zinc chromate pigments at three English factories. Br J Ind Med 41:158-169.
26. Dean, A. G., K. M. Sullivan, and M. M. Soe. 2008. OpenEpi: Open Source Epidemiologic Statistics for Public Health, Version 2.2.1. Accessed 2008/11/08, www.OpenEpi.com.
27. Deubner, D. C., M. Goodman, and J. Iannuzzi. 2001. Variability, predictive value, and uses of the beryllium blood lymphocyte proliferation test (BLPT): Preliminary analysis of the ongoing workforce survey. Appl Occup Environ Hyg 16(5):521-526.
28. Deubner, D. C., J. L. Lockey, P. Kotin, M. B. Powers, F. Miller, A. E. Rogers, and D. Trichopoulos. 2001. Re: Lung cancer case-control study of beryllium workers.
29. Sanderson W T, Ward EM, Steenland K, Petersen MR. Am. J. Ind. Med. 2001. 39:133-144.
30. Am J Ind Med 40(3):284-288.
31. Deubner, D. C., Y. W. Lowney, D. J. Paustenbach, and J. Warmerdam. 2001. Contribution of incidental exposure pathways to total beryllium exposures. Appl Occup Environ Hyg 16(5):568-578.
32. Deubner, D. C., H. D. Roth, and P. S. Levy. 2007. Empirical evaluation of complex epidemiologic study designs: Workplace exposure and cancer. J Occup Environ Med 49(9):953-959.
33. Deubner, D., and M. Kent. 2007. Keeping beryllium workers safe: An enhanced preventive model. J Occup Environ Hyg 4(3):D23-30.
34. Deubner D.C., and H.D. Roth. 2009. Rejoinder: Progress in understanding the relationship between beryllium exposure and lung cancer. Epidemiol 20. epub.
35. Doll, R., and J. Peto. 1985. Asbestos: Efects on health of exposure to asbestos: Health and Safety Commision.
36. Dutra, F. R., and E. J. Largent. 1950. Osteosarcoma induced by beryllium oxide. Am J Pathol 26(2):197-209.
37. Dutra, F. R., E. J. Largent, and J. L. Roth. 1951. Osteogenic sarcoma after inhalation of beryllium oxide. AMA Arch Pathol 51(5):473-479.
38. Eisenbud, M. 1993. Re: Lung cancer incidence among patients with berylllium disease. J Natl Cancer Inst 85:1697-1699.
39. Eisenbud, M. 1982. Origins of the standards for control of beryllium disease (1947-1949). Environ Res 27:79-88.
40. Eisenbud, M., and J. Lisson. 1983. Epidemiological aspects of beryllium-induced nonmalignant lung disease: A 30-year update. J Occup Med 25:196-202
41. ESIS. 2008. Data sheet: Result for EC#: 231-150-157, European Inventory of Existing Commercial Chemical Substances. European Chemical Substances Information System.
42. Feingold, L., D. A. Savits, and E. M. John. 1992. Use of a job-exposure matrix to evaluate parental occupation and childhood cancer. Cancer Causes Control 3:161-169.
43. Finch, G.L., M.D. Hoover, F.F. Hahn, K.J. Nikula, S.A. Belinsky, P.J. Haley, and W.C. Grifth. 1996. Animal models of beryllium-induced lung disease. Environ Health Perspect 104(Suppl 5):973-979.
44. Fodor, I. 1977. Histogenesis of beryllium-induced bone tumours. Acta Morphol Acad Sci Hung 25(2-3):99-105.
45. Garabrant, D. H. 2007. Case-control study design: Spurious associations between exposure and outcome. J Occup Environ Med 49(9):941-942.
46. Gardener, L. U., and H. F. Heslington. 1946. Osteosarcoma from intravenous beryllium compounds in rabbits. Fed Proc 5:221.
47. Gazdar, A. F. 1990. Cell biology and molecular biology of small cell and non-small cell lung cancer. Curr Opin Oncol 2(2):321-327.
48. Gillies, P. A., B. Wilcox, C. Coates, F. Kristmundsdotir, and D. J. Reid. 1982. Use of objective measurement in the validation of self-reported smoking in children aged 10 and 11 years: Saliva thiocyanate. J Epid and Commun Health 36:205-208.
49. Gordon, T., and D. Bowser. 2003. Beryllium: Genotoxicity and carcinogenicity. Mutat Res 533(1-2):99-105.
50. Greenland, S. 1980. Te efect of misclassifcation in the presence of covariates. Am J Epidemiol 112:564-569.
51. Greenland, S., and J. M. Robins. 1985. Confounding and misclassifcation. Am J Epidemiol 122:495-506
52. Greim, H, ed. 2005. Beryllium and its compounds. Vol.21, Occupational toxicants. Weinheim, Germany: Wiley-VCH.
53. Groth, D. H., C. Kommineni, and G. R. Mackay. 1980. Carcinogenicity of beryllium hydroxide and alloys. Environ Res 21(1):63-84.
54. Haley, P. J., G. L. Finch, M. D. Hoover, and R. G. Cuddihy. 1990. Te acute toxicity of inhaled beryllium metal in rats. Fundam Appl Toxicol 15(4):767-778.
55. Hext, P. M. 1994. Current perspectives on particulate induced pulmonary tumours. Hum Exp Toxicol 13:700-715.
56. Hill, A. B. 1965. Te environment and disease: Association or causation? Proc R Soc Med 58:295-300.
57. Hinds, M. W., L. N. Kolonel, and J. Lee. 1985. Application of a job-exposure matrix to a case-control study of lung cancer. J Natl Cancer Inst 75(2):193-197.
58. Hiruma, T. 1991. Rabbit osteosarcoma induced by hydroxypropylcellulose mixed beryllium oxide pellet-Comparison between implantations into bone marrow cavity and into fracture callus of the femur (Jpn.). Nippon Seikeigeka Gakkai Zasshi 65(9):775-786.
59. Hoagland, M. B., R. S. Grier, and M. B. Hood. 1950. Beryllium and growth. I. Beryllium-induced osteogenic sarcomata. Cancer Res 10(10): 629-635.
60. Hoover, J. P., D. B. Paulsen, C. W. Qualls, and R. J. Bahr. 1986. Osteogenic sarcoma with subcutaneous involvement in a rabbit. J Am Anim Hosp Assoc 9:1156-1158
61. HSDB. 1997. Beryllium, elemental: Hazardous Substances Data Bank, National Institutes of Health. http://toxnet.nlm.nih.gov/cgi-bin/sis/search/f?./ temp/~rreHS4:1. Accessed September 17, 2008.
62. HSE. 2006. Beryllium metal and beryllium compounds. In Disease reduction programme-Cancer project: Profling of occupational carcinogens.
63. Health and Safety Executive (HSE) Working Group on Action to Control Chemicals (WATCH), United Kingdom
64. IARC. 1980. IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans, Vol.23: Some metals and metallic compounds. Lyon, France: International Agency for Research on Cancer, World Health Organization
65. IARC. 1992. IARC monographs on the evaluation of carcinogenic risks to humans, Vol.54: Occupational exposures to mists and vapours from strong inorganic acids, and other industrial chemicals. Lyon, France: International Agency for Research on Cancer, World Health Organization
66. IARC. 1993. IARC monographs on the evaluation of carcinogenic risks to humans, Vol.58: Beryllium, cadmium, mercury, and exposures in the glass manufacturing industry. Lyon, France: International Agency for Research on Cancer, World Health Organization
67. IARC. 2006. IARC monographs on the evaluation of carcinogenic risks to humans: Preamble. Lyon, France: International Agency for Research on Cancer, World Health Organization
68. ILSI. 2000. Te relevance of the rat lung response to particle overload for human risk assessment: A workshop consensus report. International Life Sciences Institute (ILSI) Risk Science Institute Workshop Participants. Inhal Toxicol 12:1-17.
69. Infante, P. F., J. K. Wagoner, and N. L. Sprince. 1980. Mortality patterns from lung cancer and nonneoplastic respiratory disease among white males in the beryllium case registry. Environ Res 21(1):35-43.
70. Ishinishi, N., M. Mizunoe, T. Inamasu, and A. Hisanaga. 1980. Experimental study on carcinogenicity of beryllium oxide and arsenic trioxide to the lung of rats by an intratracheal instillation (author?s transl, Jpn.). Fukuoka Igaku Zasshi 71(1):19-26.
71. Janes, J. M., G. M. Higgins, and J. F. Herrick. 1954. Beryllium-induced osteogenic sarcoma in rabbits. J Bone Joint Surg Br 36-B(4):543-552.
72. Jarvis, M. J., H. Tunstall-Pedoe, C. Feyerabend, C. J. Vesey, and Y. Saloojee. 1987. Comparison of tests used to distinguish smokers from nonsmokers. Am J Public Health 77:1435-1438.
73. Joseph, P., T. Muchnok, and T. Ong. 2001. Gene expression profle in BALB/c-3T3 cells transformed with beryllium sulfate. Mol Carcinogen 32(1):28-35.
74. Kahn, H. A. 1966. Te Dorn study of smoking and mortality among U.S. veterans: Report on eight and one-half years of observation. Natl Cancer Inst Monograph 19:1-125.
75. Kelly, P. J., J. M. Janes, and L. F. Peterson. 1961. Te efect of beryllium on bone. A morphological study of the progressive changes observed in rabbit bone. J Bone Joint Surg Am 43-A:829-844.
76. Keshava, N., G. Zhou, M. Spruill, M. Ensell, and T. M. Ong. 2001. Carcinogenic potential and genomic instability of beryllium sulphate in BALB/c-3T3 cells. Mol Cell Biochem 222(1-2):69-76.
77. Kolanz, M. E. 2001. Introduction to beryllium: Uses, regulatory history, and disease. Appl Occup Environ Hyg 16(5):559-567.
78. Kolstad, H. A., and J. Olsen. 1999. Why do short term workers have high mortality? Am J Epidemiol 149(4):347-352.
79. Komitowski, D. 1968. Experimental beryllium-induced bone tumours as a model of osteogenic sarcoma (Pol.). Chir Narzad Ruchu Ortop Pols 33:237-242.
80. Komitowski, D. 1974. Beryllium induced bone sarcomas (author?s transl, Ger.). Verh Dtsch Ges Pathol 58:438-440.
81. Kondo, H., M. Ishikawa, H. Maeda, M. Onuma, M. Masuda, H. Shibuya, H. Koie, and T. Sato. 2007. Spontaneous osteosarcoma in a rabbit (Orcytolagus cuniculus). Vet Pathol 44:691-694.
82. Kuroda, K., G. Endo, A. Okamoto, Y. S. Yoo, and S. Horiguchi. 1991. Genotoxicity of beryllium, gallium and antimony in short-term assays. Mutat Res 264(4):163-170.
83. Lamm, S. H., M. S. Levine, J. A. Starr, and S. L. Tirey. 1988. Analysis of excess lung cancer risk in short-term employees. Am J Epidemiol 127(6):1202-1209
84. Laskin, S., R. A. N. Turner, and H. E. Stockinger, eds. 1950. An analysis of dust and fume hazards in a beryllium plant. Edited by A. Vorwald. Vol.
85. Leroy U. Gardner Memorial: Pneuonoconiosis. New York: Hoeber.
86. Lavastre, V., C. J. Roberge, M. Pelletier, M. Gauthier, and D. Girard. 2002. Toxaphene, but not beryllium, induces human neutrophil chemotaxis and apoptosis via reactive oxygen species (ROS): Involvement of caspases and ROS in the degradation of cytoskeletal proteins. Clin Immunol 104(1):40-48.
87. Lefondre, K., M. Abrahamowicz, J. Siemiatycki, and B. Rachet. 2002. Modeling smoking history: A comparison of diferent approaches. Am J Epidemiol 156:813-823.
88. Leonard, A., and R. Lauwerys. 1987. Mutagenicity, carcinogenicity and teratogenicity of beryllium. Mutat Res 186(1):35-42.
89. Levy, P. S., H. D. Roth, and D. C. Deubner. 2007. Exposure to beryllium and occurrence of lung cancer: A reexamination of fndings from a nested case-control study. J Occup Environ Med 49(1):96-101.
90. Levy, P. S., H. D. Roth, P. M. T. Hwang, and T. E. Powers. 2002. Beryllium and lung cancer: A reanalysis of a NIOSH cohort mortality study. Inhal Toxicol 14:1003-1015.
91. Litvinov, N. N., V. A. Popov, T. V. Vorozheikina, V. F. Kazenashev, and P. F. Bugryshev. 1983. Blastomogenic activities of various beryllium compounds (Russ.). Eksp Onkol 5:23-26.
92. Litvinov, N. N., V. A. Popov, T. V. Vorozheikina, V. F. Kazenashev, and P. F. Bugryshev. 1984. Data for more precise determination of the maximum allowable concentration of beryllium in the air of the workplace (Russ.). Gig Tr Prof Zabol 1:34-37.
93. MacMahon, B. 1994. Te epidemiological evidence on the carcinogenicity of beryllium in humans. J Occup Med 36(1):15-26.
94. Madl, A. K., and K. E. Pinkerton. 2008. Health efects of inhaled engineered nanoscale materials. Edited by V. H. Grassian: Nanoscience and nanotechnology: Environmental and health impacts. Hoboken, NJ: John Wiley & Sons.
95. Mancuso, T. F. 1970. Relation of duration of employment and prior respiratory illness to respiratory cancer among beryllium workers. Environ Res 3(3):251-275.
96. Mancuso, T. F. 1980. Mortality study of beryllium industry workers? occupational lung cancer. Environ Res 21(1):48-55.
97. Mancuso, T. F. 1979. Occupational lung cancer among beryllium workers. Paper read at Dusts and Disease, Society for Occupational and Environmental Health Conference, at Park Forest, IL.
98. Mancuso, T. F., and A. A. El-Attar. 1969. Epidemiological study of the beryllium industry. Cohort methodology and mortality studies. J Occup Med 11(8):422-434.
99. Matsuura, K. 1974. Experimental studies on the production of osteosarcoma by beryllium compounds, and the efects of irradiation (Jpn.). Jpn J Orthop Assoc 48:403-418.
100. Mauderly, J. L. 1996. Lung overload: Te dilemma and opportunities for resolution. Inhal Toxicol 8:1-28.
101. Mauderly, J. L., M. B. Snipes, E. B. Barr, S. A. Belinsky, J. A. Bond, A. L. Brooks, I. Y. Chang, Y. S. Cheng, N. A. Gillett, W. C. Grifth, et al. 1994. Pulmonary toxicity of inhaled diesel exhaust and carbon black in chronically exposed rats. Part 1: Neoplastic and nonneoplastic lung lesions. Res Rep Health Efects Inst 68:1-75; discussion 77-97.
102. Mazabraud, A. 1975. [Experimental production of bone sarcomas in the rabbit by a single local injection of beryllium]. Bull Cancer 62(1):49-58.
103. Mazzullo, G., M. Russo, P. P. Niiutta, and G. De Vico. 2004. Osteosrcoma with multiple metastases and subcutaneous involvement in a rabbit (Oryctolagus ciniculus). Vet Clin Path 33(2):102-104.
104. Monson, R. 1990. Case studies in occupational epidemiology. In Occupational Epidemiology, 2nd ed. Boca Raton, FL: CRC Press.
105. Morgareidge, K., G. E. Cox, and M. A. Gallo. 1976. Chronic feeding studies with beryllium in dogs. Food and Drug Research Laboratories, Inc. Submitted to the Aluminum Company of America, Alcan Research & Development, Ltd., Kawecki-Berylco Industries, Inc., and Brush-Wellman, Inc.
106. Nesnow, S., L. L. Triplett, and T. J. Slaga. 1985. Studies on the tumor initiating, tumor promoting, and tumor co-initiating properties of respiratory carcinogens. Carcinogenesis 8:257-277.
107. Nickell-Brady, C., F. F. Hahn, G. L. Finch, and S. A. Belinsky. 1994. Analysis of K-ras, p53 and c-raf-1 mutations in beryllium-induced rat lung tumors. Carcinogenesis 15(2):257-262.
108. Nikula, K. J., D. S. Swaford, M. D. Hoover, M. D. Tohulka, and G. L. Finch. 1997. Chronic granulomatous pneumonia and lymphocytic responses induced by inhaled beryllium metal in A/J and C3H/HeJ mice. Toxicol Pathol 25(1):2-12
109. NIOSH. 2005. Pocket guide to chemical hazards, beryllium and beryllium compounds, DHEW (NIOSH) Publication No. 2005-2151.
110. Washington, DC: National Institute for Occupational Safety and Health. NTP. 2005. Report on carcinogens, eleventh Edition: Beryllium and beryllium compounds: U.S. Department of Health and Human Services, Public Health Service, National Toxicology Program, Washington, DC.
111. OECD. 1997. Guidelines for the Testing of Chemicals. Organisation for Economic Co-operation and Development (OECD). Available at http:// titania.sourceoecd.org/vl=3043871/cl=19/nw=1/rpsv/cw/vhosts/ oecdjournals/1607310x/v1n4/contp1-1.htm.
112. Ohlson, C. G., and C. Hogstedt. 1985. Lung cancer among asbestos cement workers. A Swedish cohort study and review. Br J Ind Med 42:397-402.
113. OSHA. 1977. Informal standard for exposure to beryllium. Transcript of proceedings, August 31, 1977. Washington, DC: U.S. Department of Labor, Occupational Safety and Health Administration
114. OSHA. 1989. OSHA Permissible Exposure Limits. 29 CFR 1910.1000, Table Z-1. Washington, DC: U.S. Department of Labor, Occupational Safety and Health Administration.
115. Paustenbach, D. J. 1989. Important recent advances in the practice of health risk assessment: implications for the 1990s. Regul Toxicol Pharmacol 10(3):204-243
116. Peer Review Summary Report. 2008. Consolidated Comments from the External Peer Review Meeting on the Toxicological Review of Beryllium and Compounds (CAS No. 7440-41-7), Prepared for the U.S. EPA: Available at http://cfpub.epa.gov/ ncea/cfm/recordisplay. cfm?deid=189634.
117. Pfeifer, A. M., G. E. Mark, 3rd, L. Malan-Shibley, S. Graziano, P. Amstad, and C. C. Harris. 1989. Cooperation of c-raf-1 and c-myc protooncogenes in the neoplastic transformation of simian virus 40 large tumor antigen-immortalized human bronchial epithelial cells. Proc Natl Acad Sci USA 86(24):10075-10079.
118. Rana, S. V. 2008. Metals and apoptosis: Recent developments. J Trace Elem Med Biol 22(4):262-284.
119. Reeves, A. L., D. Deitch, and A. J. Vorwald. 1967. Beryllium carcinogenesis. I. Inhalation exposure of rats to beryllium sulfate aerosol. Cancer Res 27(3):439-445.
120. Renfrew, H., and J. R. Rest. 2001. Extraskeletal fbroblastic osteosarcoma in a rabbit (Oryctolagus cuniculus). J Small Anim Pract 42:456-458.
121. Richiardi, L., F. Forastiere, P. Bofetta, L. Simonato, and F. Merletti. 2005. Efect of diferent approaches to treatment of smoking as a potential confounder in a case-control study on occupational exposures. Occup Environ Med 62:101-104
122. Rossman, M. D., O. P. Preuss, and M. B. Powers, eds. 1991. Beryllium: Bio medical and environmental aspects. Baltimore, MD: Williams & Wilkins.
123. Rothman, K. J., S. Greenland, and T. L. Lash. 2008. Modern epidemiology, 3rd ed. Philadelphia, PA: Lippincott, Williams & Wilkins.
124. Salm, R., and J. Field. 1965. Osteosarcoma in a rabbit. J Pathol Bacteriol 89:400-402.
125. Sanderson, W. T. 2001c. Re: Response to criticisms of "Lung Cancer Case-Control Study of Beryllim Workers." Am J Ind Med 40:286-288.
126. Sanderson, W. T., E. M. Ward, K. Steenland, and M. R. Petersen. 2001b. Lung cancer case-control study of beryllium workers. Am J Ind Med 39(2):133-144.
127. Sanderson, W. T., M. R. Peterson, and E. M. Ward. 2001a. Estimating historical exposures of workers in a beryllium manufacturing plant. Am J Ind Med 39:145-157.
128. Saracci, R. 1985. Interpretation of negative epidemiological evidence for carcinogenicity. IARC Sci Publ 65.
129. Schepers, G. W. 1961. Neoplasia experimentally induced by beryllium compounds. Prog Exp Tumor Res 2:203-244.
130. Schepers, G. W., F. T. Creedon, A. B. Delahant, and T. M. Durkan. 1957. Te biological action of inhaled beryllium sulfate; a preliminary chronic toxicity study on rats. AMA Arch Ind Health 15(1):32-58.
131. Schroeder, H. A., and M. Mitchener. 1975. Life-term studies in rats: Efects of aluminum, barium, beryllium, and tungsten. J Nutr 105(4):421-427.
132. Schubauer-Berigan, M. K., J. A. Deddens, and M. R. Petersen. 2007. Re: exposure to beryllium and occurrence of lung cancer: A reexamination of fndings from a nested case-control study. J Occup Environ Med 49(7):708-709; author reply 709-711.
133. Schubauer-Berigan, M. K., J. A. Deddens, K. Steenland, W. T. Sanderson, and M. R. Petersen. 2008. Adjustment for temporal confounders in a reanalysis of a case-control study of beryllium and lung cancer. Occup Environ Med 65(6):379-383.
134. Sivulka, D. J. 2006. Comparison of non neoplastic respiratory responses in animals after inhalation of water soluble and insoluble metal compounds: White paper available from Nickel Producers Environmental Research Association NiPERA, Toronto, Canada.
135. Sprince, N. L. 1986. Beryllium disease. In: Occupational Respiratory Diseases. Edited by J. Merchant, B. Boehlecke and G. Taylor. Washington, DC: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health.
136. Stayner, L., K. Steenland, M. Dosemeci, and I. Hertz-Picciotto. 2003. Attenuation of exposure-response curves in occupational cohort studies at high exposure levels. Scand J Work Environ Health 29(4):317-324.
137. Steenland, K., and E. Ward. 1991. Lung cancer incidence among patients with beryllium disease: A cohort mortality study. J Natl Cancer Inst 83(19):1380-1385.
138. Stewart, P. A., C. Schairer, and A. Blair. 1990. Comparison of jobs, exposures, and mortality risks or short-term and long-term workers. J Occup Med 32(8):703-708.
139. Stram, D. O., M. Huberman, and A. H. Hu. 2002. Is residual confounding a reasonable explanation for the apparent protective efects of beta-carotene found in epidemiologic studies of lung cancer in smokers? Am J Epidemiol 155:622-628.
140. Stulbarg, M. S., and L. Simmerman. 1996. Chronic obstructive pulmonary disease. In Occupational and Environmental Respiratory Diseases. Edited by P. Harber, M. Scheneker and J. Balmer. St. Louis, MO: Mosby.
141. Tapp, E. 1966. Beryllium induced sarcomas of the rabbit tibia. Br J Cancer 20(4):778-783.
142. Tapp, E. 1969. Osteogenic sarcoma in rabbits. Following subperiosteal implantation of beryllium. Arch Pathol 88(1):89-95.
143. Turton, J., and J. Hooson. 1998. Target organ pathology: A basic text. London: Taylor & Francis.
144. U.S. EPA. 1987. Health assessment document for beryllium. EPA/600/884 026F. Research Triangle Park, NC: U.S. Environmental Protection Agency.
145. U.S. EPA. 1991. Drinking water criteria document for beryllium. NTIS PB92-173301. Cincinnati, OH: Ofce of Health and Environmental Assessment, Environmental Criteria and Assessment Ofce for the Ofce of Drinking Water, U.S. Environmental Protection Agency.
146. U.S. EPA. 1998. Toxicological review of beryllium and compounds (CAS No. 7440-41-7), in supprt of summary information on the Integrated Risk Information System (IRIS). EPA/635/R-98/008. Washington, DC: U.S. Environmental Protection Agency.
147. U.S. EPA. 2005. Guidelines for Carcinogen Risk Assessment. EPA/630/P-03/001F. Washington, DC: U.S. Environmental Protection Agency. U.S. EPA. 2008. IRIS toxicological review of beryllium (External review draft). EPA/635/R-08/009A. Washington, DC: U.S. Environmental Protection Agency.
148. U.S. Surgeon General. 1985. Te health consequences of smoking. Cancer and chronic lung disease in the workplace. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service.
149. Vacher, J., and H. B. Stoner. 1968. Te transport of beryllium in rat blood. Biochem Pharmacol 17(1):93-107.
150. Vesey, C. J., Y. Saloojee, P. V. Cole, and M. A. H. Russell. 1982. Blood carboxyhaemoglobin, plasma thiocyanage, and cigarette consumption: Implications for epidemiological studies in smokers. Br J Med 284:1516-1518.
151. Vorwald, A. J. 1966. Te induction of experimental pulmonary cancer in the primate. Paper read at Proc 9th Int Cancer Congress, Tokyo, Japan.
152. Wagner, W. D., D. H. Groth, J. L. Holtz, G. E. Madden, and H. E. Stokinger. 1969. Comparative chronic inhalation toxicity of beryllium ores, bertrandite and beryl, with production of pulmonary tumors by beryl. Toxicol Appl Pharmacol 15:10-29.
153. Wagoner, J. K., P. F. Infante, and D. L. Bayliss. 1980. Beryllium: An etiologic agent in the induction of lung cancer, nonneoplastic respiratory disease, and heart disease among industrially exposed workers. Environ Res 21(1):15-34.
154. Walberg, J. A. 1981. Osteogenic sarcoma with metastasis in a rabbit (Oryctolagus cuniculus). Lab Anim Sci 31(4):407-408.
155. Ward, E., A. Okun, A. Ruder, M. Fingerhut, and K. Steenland. 1992. A mortality study of workers at seven beryllium processing plants. Am J Ind Med 22(6):885-904.
156. Weisbroth, S. H., and A. Hurvits. 1969. Spontaneous osteogenic sarcoma in Oryctolagus cuniculus with elevated serum alkaline phosphatase. Lab Anim Care 19(2):263-265.
157. WHO. 2001. Beryllium and beryllium compounds. Geneva: Concise International Chemical Assessment Document 32, World Health Organization.
158. Yamaguchi, S. 1963. Study of beryllium-induced oseogenic sarcoma (Jpn.). Nagasaki Iggakai Zasshi 38:127-138.
159. Zorn, H., T. Stiefel, and H. Diem. 1977. Importance of beryllium and its compunds in occupational medicine. Part 2 (Ger.). Zbl. Arbeitsmed 27:83-88